Therefore, the primary aim of this systematic review and meta-analysis was to give an up-to-date comprehensive overview of the effect of CGM (rtCGM or isCGM) compared with SMBG on glycaemic control, as quantified by HbA1c, in adults with type 2 diabetes treated with or without insulin. The gene discussed is INS; the disease is type 2 diabetes mellitus.